1 / 6

Drug Addiction Therapeutic Assessment Pipeline Review H1 2015

This report gives extensive data on the helpful improvement for Drug Addiction, complete with relative examination at different stages, therapeutics appraisal by medication target, instrument of activity (MoA), course of organization (RoA) and particle sort, alongside most recent upgrades, and included news and press discharges. It likewise surveys key players included in the remedial improvement for Drug Addiction and uncommon elements on late-stage and stopped activities.

jack2222simon
Télécharger la présentation

Drug Addiction Therapeutic Assessment Pipeline Review H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Addiction - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Market Direct Date: 29-May-2015 No. of pages: 90 Single User License: US $2000 Browse more Reports on Diseases & treatment at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/diseases-treatment . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Drug Addiction - Pipeline Review, H1 2015 This report gives extensive data on the helpful improvement for Drug Addiction, complete with relative examination at different stages, therapeutics appraisal by medication target, instrument of activity (MoA), course of organization (RoA) and particle sort, alongside most recent upgrades, and included news and press discharges. It likewise surveys key players included in the remedial improvement for Drug Addiction and uncommon elements on late-stage and stopped activities. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Drug Addiction - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research : Addex Therapeutics Ltd, Aphios Corporation, Curemark, LLC, EmberaNeuroTherapeutics, Inc., Gilead Sciences, Inc., Immunovaccine, Inc., Kyorin Pharmaceutical Co., Ltd., Lightlake Therapeutics Inc., Omeros Corporation, RottapharmSpA and Teva Pharmaceutical Industries Limited Drugs Profile Discussed in this Research : (oxazepam + metyrapone), ADX-71441, ADX-88178, cannabidiol, CM-1212, CR-5542 Series, dronabinol, Drug for Dependence, GS-6637, ibudilast, LT-22, MC-100093, Methoxycoronaridine, OMS-527, Small Molecule for Drug Addiction, Small Molecule to Activate Kappa Opioid Receptor for CNS, Small Molecule to Inhibit BRD for Cocaine Dependence, Small Molecule to Inhibit Kappa Opioid Receptor for CNS, Small Molecules to Activate Delta Opioid Receptor for Immunology, CNS and Metabolic Disorders, Small Molecules to Inhibit CB1 Receptor for Cannabinoid Abuse and Drug Addiction, Small Molecules to Inhibit DAT and SERT for CNS Disorders, Small Molecules to Modulate 5HT2 for CNS and Metabolic Disorders, TV-1380, Vaccine for Cocaine Addiction, Vaccine for Cocaine Addiction and Vaccine for Methamphetamine Addiction ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Drug Addiction - Pipeline Review, H1 2015 Scope For Drug Addiction - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Drug Addiction • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Drug Addiction and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Drug Addiction products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Drug Addiction - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Drug Addiction • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Drug Addiction pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Drug Addiction - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related